Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-000976
Filing Date
2024-05-15
Accepted
2024-05-15 16:06:19
Documents
48
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q g084223_10q.htm   iXBRL 10-Q 756638
2 EXHIBIT 10.1 g084223_ex10-1.htm EX-10.1 23556
3 EXHIBIT 10.2 g084223_ex10-2.htm EX-10.2 36238
4 EXHIBIT 10.3 g084223_ex10-3.htm EX-10.3 88879
5 EXHIBIT 31.1 g084223_ex31-1.htm EX-31.1 12674
6 EXHIBIT 32.1 g084223_ex32-1.htm EX-32.1 6801
  Complete submission text file 0001753926-24-000976.txt   3981221

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE chro-20240331.xsd EX-101.SCH 35118
8 XBRL CALCULATION FILE chro-20240331_cal.xml EX-101.CAL 29966
9 XBRL DEFINITION FILE chro-20240331_def.xml EX-101.DEF 111830
10 XBRL LABEL FILE chro-20240331_lab.xml EX-101.LAB 282887
11 XBRL PRESENTATION FILE chro-20240331_pre.xml EX-101.PRE 199619
52 EXTRACTED XBRL INSTANCE DOCUMENT g084223_10q_htm.xml XML 445398
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41964 | Film No.: 24950456
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)